3Berg AH,Scherer PE.Adipose tissue,inflammation and cardiovascular disease[J].Circ Res,2005,96 (9):939-949.
4Lehrke M,Reilly MP,Millington SC,et al.An inflammatory cascade leading to hyperresistinemia in humans[J].PLoS Med,2004,1(2):e45.
5Axelsson J,Bergsten A,QureshiAR,et al.Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation,but not with insulin resistance[J].Kidney Int,2006,69 (3):5962-6041.
6Reilly MP,Lehrke M,Wolfe ML,et al.Resistin is an inflammat orymarker of atherosclerosis in humans[J].Circulation,2005,111(7):9322-9391.
7Piestrzeniewicza K,Luczaka K,Komorowski,et al.Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction[J].Metab Clin Exp,2008,57(4):4882-4931.
8Lubos E,Messow CM,Schnabel R,et al.Resistin,acute coronary syndrome and prognosis results from the Athero Gene study[J].Atherosclerosis,2007,193 (1):1212-1281.
9Curat CA,Wegner V,Sengenes C,et al.Machrophages in human Visceral adipose tissue:increased accumulation in obesity and a source of resisitent and Visfatin[J].Dibetologia,2006,49 (4):744-747.
10Kim SR,Bae YH,Bae SK.Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κb activation in endothelial cells[J].Biochimicaet Biophysica Acta,2008,1783(3):886-895.
二级参考文献32
1Siller-Matula JM, Lang I, Christ G, et al. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol, 2008,52:1564-1566.
2Scarbelli T, Stephanou A, Rayment N, et at. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/ reperfusion injury. Circulation ,2001,104:253-256.
3Honda T, Kaikita K, Tsujita K, et al. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders. J Mol Cell Cardiol, 2008,44:915-926.
4Elrod JW, Harrell M, Flagg TP, et al. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury. Circulation, 2008,117 : 1405-1413.
5Blokhin IO, Vlasov TD, Galagudza MM, et al. Role of sodium- calcium exchanger in myocardial protection against ischemia- reperfusion injury. Ross Fiziol Zh Im I M Sechenova, 2008, 94: 284 -292.
6Black SC, Huang JQ, Rezaiefar P, et al. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol, 1998,30:733-742.
7Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature, 1998, 391:82-86.
8Borger DR, Gayrilescu LC, Bucur MC, et al. AMP-activated protein kinase is essential for survival in chronic hypoxia. Biochem Biophys Res Commun, 2008,370:230-234.
9Steinberg GR, Michell B J, van Denderen BJ,et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab, 2006, 4 : 465- 474.
10Yamaguchi N, Kukita T, Li YJ, et al. Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATcl via the AMPK signaling. FEBS Lett, 2008,582:451-456.
